Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-25-091656
Filing Date
2025-09-19
Accepted
2025-09-19 16:15:06
Documents
2

Document Format Files

Seq Description Document Type Size
1 DEFA14A pahc-20250919xdefa14a.htm DEFA14A 30619
2 GRAPHIC pahc-20250919xdefa14a006.jpg GRAPHIC 35357
  Complete submission text file 0001104659-25-091656.txt   80690
Mailing Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666
Business Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666 201-329-7300
PHIBRO ANIMAL HEALTH CORP (Filer) CIK: 0001069899 (see all company filings)

EIN.: 131840497 | State of Incorp.: DE | Fiscal Year End: 0630
Type: DEFA14A | Act: 34 | File No.: 001-36410 | Film No.: 251327000
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)